Insider Stock Trading History of Polaris Venture Partners Special Founders' Fund V, L.p.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Polaris Venture Partners Special Founders' Fund V, L.p. since year 2005. The trader's CIK number is 1439586. At the time of this reporting, Polaris Venture Partners Special Founders' Fund V, L.p. is the 10% Owner of Selecta Biosciences Inc . (stock ticker symbol SELB). See this page for all insider trading activities at Selecta Biosciences Inc .

Note that in the past Polaris Venture Partners Special Founders' Fund V, L.P. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Polaris Venture Partners Special Founders' Fund V, L.p. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-06-27 SELB Selecta Biosciences Inc Buy 150,000 14.00 2,100,000
2015-06-18 GNCA Genocea Biosciences, Inc. Sale 29,004 13.04 378,212
2015-06-19 GNCA Genocea Biosciences, Inc. Sale 1,000 13.00 13,000
2015-06-15 PULM Ruthigen, Inc. Buy 106,693 6.88 733,514
2015-06-16 GNCA Genocea Biosciences, Inc. Sale 46,000 13.24 609,040
2015-06-17 GNCA Genocea Biosciences, Inc. Sale 10,618 13.01 138,140
2015-02-02 OCUL Ocular Therapeutix, Inc Sale 500,000 29.50 14,750,000
2014-08-13 GNCA Genocea Biosciences, Inc. Sale 2,905 13.00 37,765
2014-08-14 GNCA Genocea Biosciences, Inc. Sale 6,755 13.01 87,882
2014-08-08 GNCA Genocea Biosciences, Inc. Sale 41,376 13.41 554,852
2014-08-11 GNCA Genocea Biosciences, Inc. Sale 1,428 13.24 18,906
2014-08-12 GNCA Genocea Biosciences, Inc. Sale 20,990 13.03 273,499
2014-04-15 CERU Cerulean Pharma Inc. Buy 1,470,582 7.00 10,294,074
2013-10-04 FATE Fate Therapeutics Inc Buy 833,333 6.00 4,999,998

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner of Selecta Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.